Prevalence of intentions to receive monkeypox vaccine. A systematic review and meta-analysis

León-Figueroa, Darwin A.; Barboza, Joshuan J.; Valladares-Garrido, Mario J.; Sah, Ranjit; Rodriguez-Morales, Alfonso J.

doi:10.1186/s12889-023-17473-y

Cited by 4 publications

(2 citation statements)

References 52 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The effectiveness and safety of mpox vaccine have been confirmed by several studies [ 9 , 10 ]. Based on the results of our review and the study by León-Figueroa et al [ 58 ], people who were confident in the safety and efficacy of the mpox vaccine were more likely to be vaccinated. Therefore, experts should develop and promote a global consensus on mpox vaccination.…”

Section: Discussionmentioning

confidence: 84%

Willingness to receive mpox vaccine among men who have sex with men: a systematic review and meta-analysis

Liu,

et al. 2024

BMC Public Health

View full text Add to dashboard Cite

Background Since May 2022, mpox outbreaks have been occurring in non-mpox endemic areas, with the main population affected being men who have sex with men (MSM). Outbreak prevention and control depend not only on the effectiveness of vaccines but also on people’s willingness to receive these vaccines. Currently, there is lack of synthesis on the overall rates and influence factors of MSMs’ willingness to vaccinate against mpox. Therefore, we systematically reviewed studies that assessed the willingness of MSM to receive mpox vaccine. Methods Studies reporting mpox vaccination intentions among MSM were included by searching five databases (PubMed, Web of Science, EMBASE, CINAHL, and SCOPUS) from inception to May 12, 2024. The quality of the included literature was assessed using Joanna Briggs Institute’s critical appraisal tool. The data analysis software is Stata17. The systematic review has been registered with Prospero (registration ID: CRD42023452357). Results Twenty cross-sectional studies were included in the review. Meta-analysis results showed that the pooled willingness rate of vaccinate against mpox was 77.0% (95% CI: 73-81%, I2 = 99.4%). According to subgroup analysis, study countries (P = 0.002), research sample size (P = 0.001), and whether participants were infected with HIV (P = 0.002) may be sources of heterogeneity. The results of the meta-analysis of influencing factors showed that more number of sexual partners (OR: 2.24, 95%CI: 1.86–2.69), pre-exposure prophylaxis use (OR: 6.04, 95%CI: 4.80–7.61), history of sexually transmitted infections (OR: 2.96, 95%CI: 2.33–3.76), confidence in the vaccine’s effectiveness (OR: 2.79, 95%CI: 2.04–3.80) and safety (OR: 10.89, 95%CI: 5.22–22.72), fear of mpox infection (OR: 2.47, 95%CI: 2.11–2.89) and epidemics (OR: 2.87, 95%CI: 2.22–3.70), high mpox knowledge (OR: 2.35, 95%CI: 1.51–3.66), and the belief that people at high risk should be prioritized for vaccination (OR: 3.09, 95%CI: 1.40–6.84) were the facilitators of vaccine willingness. In addition, as a secondary outcome, meta-analysis results showed a pooled unwillingness rate of 16% (95% CI: 13-20%, I2 = 98.1%, 9 studies). Conclusion Willingness to vaccinate mpox was high among MSM, but some participants still had negative attitudes towards vaccination. Therefore, the Ministry of Public Health should develop targeted and effective strategies against those influencing factors to prevent and manage mpox outbreaks.

show abstract

Section: Discussionmentioning

confidence: 84%

Willingness to receive mpox vaccine among men who have sex with men: a systematic review and meta-analysis

Liu,

et al. 2024

BMC Public Health

View full text Add to dashboard Cite

show abstract

“…A meta-analysis of 29 studies involving 52,658 participants demonstrated that the pooled prevalence of the intention to vaccinate against mpox was 61% around the world [ 10 ]. However, people’s willingness to receive mpox vaccination does not guarantee that they will get vaccinated [ 11 ].…”

Section: Introductionmentioning

confidence: 99%

Factors Related to Mpox-Vaccine Uptake among Men Who Have Sex with Men in Taiwan: Roles of Information Sources and Emotional Problems

Huang,

Chang,

Lin

et al. 2024

Vaccines

View full text Add to dashboard Cite

An mpox outbreak occurred suddenly and rapidly spread worldwide in 2022. Research has demonstrated a link between the sexual behavior of men who have sex with men (MSM) and the contraction of mpox. This study assessed the factors related to mpox-vaccine uptake among MSM in Taiwan, focusing on the roles of information sources and emotional problems. In total, 389 MSM participated in an online survey. Data on the participants’ vaccination statuses; anxiety symptoms, which were assessed using the State–Trait Anxiety Inventory; depressive symptoms, which were assessed using the Center for Epidemiologic Studies Depression Scale; and risk perceptions of contracting mpox were collected. Factors related to mpox-vaccine uptake were examined using a multivariable logistic regression model. The results revealed that MSM who were older (p < 0.001), perceived a higher risk of contracting mpox (p = 0.040), and received mpox information from health-care providers (p < 0.001) were more likely to receive mpox vaccination, whereas MSM who reported a greater severity of depression (p = 0.017) were less likely to receive mpox vaccination. However, age did not moderate the associations of perceiving a higher risk of contracting mpox, receiving mpox information from health-care providers, and depression with having an mpox vaccination. Health-care providers should consider these factors when developing intervention programs for enhancing mpox-vaccine uptake among MSM.

show abstract

Do self-rated health and previous vaccine uptake influence the willingness to accept MPOX vaccine during a public health emergency of concern? A cross-sectional study

Braimah,

Achore,

Dery

et al. 2024

PLOS Glob Public Health

View full text Add to dashboard Cite

Monkeypox (MPOX) was declared a global public health emergency of international concern in July 2022. Vaccinations may be an essential strategy to prevent MPOX infections and reduce their impact on populations, especially among at-risk populations. However, less is known about the factors associated with people’s willingness to accept the MPOX vaccine in resource-constrained settings. In this study, we examine the associations between self-rated health, previous vaccine uptake, and people’s willingness to accept the MPOX vaccine using cross-sectional data from four major cities in Ghana. The data were analyzed using descriptive and logistic regression techniques. We found that the acceptance of the MPOX vaccine is generally low (approximately 32%) in Ghana. The regression analysis reveals that individuals who did not receive vaccines in the past are much less likely to get the MPOX vaccine (AOR:.28; 95% CI:.62–2.37). The association between self-rated health and vaccine acceptance (AOR: 1.22; 95% CI:.62–2.37) disappeared after we accounted for covariates. Based on these findings, we conclude that vaccine uptake history may be critical to people’s uptake of the MPOX vaccine.

show abstract

Prevalence of intentions to receive monkeypox vaccine. A systematic review and meta-analysis

Cited by 4 publications

References 52 publications

Willingness to receive mpox vaccine among men who have sex with men: a systematic review and meta-analysis

Willingness to receive mpox vaccine among men who have sex with men: a systematic review and meta-analysis

Factors Related to Mpox-Vaccine Uptake among Men Who Have Sex with Men in Taiwan: Roles of Information Sources and Emotional Problems

Do self-rated health and previous vaccine uptake influence the willingness to accept MPOX vaccine during a public health emergency of concern? A cross-sectional study

Contact Info

Product

Resources

About